Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease

As demand for clinical next-generation sequencing grows, Illumina Connected Insights enables user to streamline data interpretation and report generation to inform precision care SAN DIEGO, March 27, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and…

Click here to view original post